Inhibrx Biosciences INBX
NASDAQ INBX
$87.00 -3.59 (-3.96%)
As of: Nov 12, 2026 · 9:41 AM EST

Inhibrx Biosciences (INBX) Return on Invested Capital [ROIC] (2024 - 2026)

Updated

Inhibrx Biosciences (INBX) posted Return on Invested Capital [ROIC] of -107.20% for Q2 2026, down 14.65 percentage points from -92.55% a year earlier.

Analysis

Inhibrx Biosciences (INBX) Return on Invested Capital [ROIC] (2024 - 2026) Analysis & Trends

For FY2025, Inhibrx Biosciences' Return on Invested Capital [ROIC] came in at -111.53%, up 61.08 percentage points from FY2024.

  • In prior years, Inhibrx Biosciences' Return on Invested Capital [ROIC] was -172.60% in FY2024.
  • Quarterly Return on Invested Capital [ROIC] has run from a low of -212.43% in Q4 2024 to a high of -92.55% in Q2 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.57%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.28%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.52%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 23.11%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 15.60%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.11%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 12.34%
10 Inhibrx Biosciences 1.33 Bn 760.41 Mn - -92.19%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -92.19%
Mar 31, 2026 -93.75%
Dec 31, 2025 -110.09%
Sep 30, 2025 -101.14%
Jun 30, 2025 -92.55%
Mar 31, 2025 -183.99%
Dec 31, 2024 -212.43%
Sep 30, 2024 -185.91%
API Access

Inhibrx Biosciences Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=INBX&period=max&api_key=YOUR_API_KEY